title: [Assessing the direct cost of medical care for HIV between the third and tenth year of ARV treatment in Dakar].
abstract: The direct cost of medical care for HIV infection-excluding ARVs, viral load and CD4 counts-was assessed for patients who received ARV treatment in Senegal within the framework of the ANRS cohort 1215, between the third and tenth year of follow-up. The average annual direct cost was estimated at 120 <euro>/patient/year; this amount remained stable over the first ten years of treatment follow-up. Biological assessments for routine follow-up account for the majority of these costs (66%), followed by drugs (26%). Given the level of economic poverty facing by families, patients cannot bear such expenses over several years. However, these costs appear low enough to be covered by HIV-treatment programs or included in Universal Health Coverage systems.
authors.affiliation: Centre régional de recherche et de formation à la prise en charge clinique, CHU de Fann à Dakar, Dakar, Sénégal (CRCF).
authors.forename: S
authors.initials: S
authors.lastname: Boufkhed
authors.forename: B
authors.initials: B
authors.lastname: Taverne
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D017281:Cost of Illness; D016527:Drug Costs; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D015497:HIV-1; D006801:Humans; D008134:Long-Term Care / Q000191:economics; D008297:Male; D008875:Middle Aged; D012675:Senegal / Q000453:epidemiology; D016019:Survival Analysis